HDAC inhibitors have been shown to suppress cell proliferation in vitro and in vivo11–13, and can also rapidly alter micro (mi)RNA levels to induce cell apoptosis in breast and pancreatic cancer and cholangiocarcinoma cells14–16. Here, HDAC9 is linked to pancreatic neoplasm.